Cellular fibronectin exacerbates α-synuclein aggregation via integrin alpha4beta1 mediated PARP1 and SCD elevation.

Huang Z, Zhong H, Lu Y, Yu R, Zhang M, Zheng J, Xiao B, Zhou Z, Yu Y, Deng C, Jin K, Zhu S, Li C, Cui X, Poplawska-Domaszewicz K, Chaudhuri KR, Tan EK, Wang Q

Open source

DOI
10.1016/j.neurot.2025.e00729
Published
2025 Oct
Container
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neurot.2025.e00729,
  title = {Cellular fibronectin exacerbates α-synuclein aggregation via integrin alpha4beta1 mediated PARP1 and SCD elevation.},
  author = {Huang Z and Zhong H and Lu Y and Yu R and Zhang M and Zheng J and Xiao B and Zhou Z and Yu Y and Deng C and Jin K and Zhu S and Li C and Cui X and Poplawska-Domaszewicz K and Chaudhuri KR and Tan EK and Wang Q},
  year = {2025},
  journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
  doi = {10.1016/j.neurot.2025.e00729},
  url = {https://doi.org/10.1016/j.neurot.2025.e00729}
}

RIS

TY  - JOUR
TI  - Cellular fibronectin exacerbates α-synuclein aggregation via integrin alpha4beta1 mediated PARP1 and SCD elevation.
AU  - Huang Z
AU  - Zhong H
AU  - Lu Y
AU  - Yu R
AU  - Zhang M
AU  - Zheng J
AU  - Xiao B
AU  - Zhou Z
AU  - Yu Y
AU  - Deng C
AU  - Jin K
AU  - Zhu S
AU  - Li C
AU  - Cui X
AU  - Poplawska-Domaszewicz K
AU  - Chaudhuri KR
AU  - Tan EK
AU  - Wang Q
PY  - 2025
JO  - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
DO  - 10.1016/j.neurot.2025.e00729
UR  - https://doi.org/10.1016/j.neurot.2025.e00729
ER  - 

APA

Z, H., H, Z., Y, L., R, Y., M, Z., J, Z., B, X., Z, Z., Y, Y., C, D., K, J., S, Z., C, L., X, C., K, P., KR, C., EK, T., & Q, W. (2025). Cellular fibronectin exacerbates α-synuclein aggregation via integrin alpha4beta1 mediated PARP1 and SCD elevation.. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. https://doi.org/10.1016/j.neurot.2025.e00729

Source records